Cytokines as biomarkers of Crimean-Congo hemorrhagic fever

Journal of Medical Virology

Volumn 88, Issue 1, 2016, Pages 21-27

  Papa, Anna ^a   Tsergouli, Katerina ^a   Çağlayik, Dilek Yağci ^b   Bino, Silvia ^c   Como, Najada ^d   Uyar, Yavuz ^e   Korukluoglu, Gulay ^b  

^a ARISTOTLE UNIVERSITY OF THESSALONIKI   (Greece)

^b Public Health Institution of Turkey   (Turkey)

^c Institute of Public Health   (Albania)

^d UNIVERSITY HOSPITAL CENTER MOTHER TERESA   (Albania)

^e ISTANBUL UNIVERSITY   (Turkey)

Author keywords

Biomarkers; Chemokines; Crimean Congo hemorrhagic fever; Cytokines

Indexed keywords

BIOLOGICAL MARKER; CYTOKINE; EOTAXIN; FIBROBLAST GROWTH FACTOR 2; GAMMA INTERFERON; GAMMA INTERFERON INDUCIBLE PROTEIN 10; GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR; INTERLEUKIN 1 RECEPTOR BLOCKING AGENT; INTERLEUKIN 10; INTERLEUKIN 12; INTERLEUKIN 13; INTERLEUKIN 15; INTERLEUKIN 17; INTERLEUKIN 1BETA; INTERLEUKIN 2; INTERLEUKIN 4; INTERLEUKIN 5; INTERLEUKIN 6; INTERLEUKIN 7; INTERLEUKIN 8; INTERLEUKIN 9; MACROPHAGE INFLAMMATORY PROTEIN 1ALPHA; MACROPHAGE INFLAMMATORY PROTEIN 1BETA; MONOCYTE CHEMOTACTIC PROTEIN 1; PLATELET DERIVED GROWTH FACTOR BB; RANTES; TUMOR NECROSIS FACTOR ALPHA; VASCULOTROPIN;

ADULT; AGED; ALBANIA; ARTICLE; CHILD; CLINICAL ARTICLE; CONTROLLED STUDY; CRIMEAN CONGO HEMORRHAGIC FEVER; CRIMEAN CONGO HEMORRHAGIC FEVER VIRUS; CYTOKINE RELEASE; CYTOKINE STORM; DISEASE SEVERITY; FEMALE; GREECE; HUMAN; IMMUNE RESPONSE; MALE; REAL TIME POLYMERASE CHAIN REACTION; RNA EXTRACTION; SURVIVOR; TH1 CELL; TURKEY (REPUBLIC); VIRUS LOAD; ADOLESCENT; BLOOD; MIDDLE AGED; PATHOLOGY; PRESCHOOL CHILD; VIROLOGY; YOUNG ADULT;

ADOLESCENT; ADULT; AGED; BIOMARKERS; CHILD; CHILD, PRESCHOOL; CYTOKINES; FEMALE; HEMORRHAGIC FEVER, CRIMEAN; HUMANS; MALE; MIDDLE AGED; VIRAL LOAD; YOUNG ADULT;

EID: 84945443041     PISSN: 01466615     EISSN: 10969071     Source Type: Journal    
DOI: 10.1002/jmv.24312     Document Type: Article

References (36)

1. Bakir M, Bakir S, Sari I, Celik VK, Gozel MG, Engin A. 2013. Evaluation of the relationship between serum levels of VEGF and sVEGFR1 with mortality and prognosis in patients with Crimean-Congo hemorrhagic fever. J Med Virol 85:1794-1801.
2. Bodur H, Akinci E, Onguru P, Uyar Y, Basturk B, Gozel MG, Kayaaslan BU. 2010. Evidence of vascular endothelial damage in Crimean-Congo hemorrhagic fever. Int J Infect Dis 14:e704-e707.
3. Bray M. 2005. Pathogenesis of viral hemorrhagic fever. Curr Opin Immunol 17:399-403.
4. Bray M, Geisbert TW. 2005. Ebola virus: The role of macrophages and dendritic cells in the pathogenesis of Ebola hemorrhagic fever. Int J Biochem Cell Biol 37:1560-1566.
5. Carrol ED, Thomson AP, Mobbs KJ, Hart CA. 2000. The role of RANTES in meningococcal disease. J Infect Dis 182:363-366.
6. Cevik MA, Erbay A, Bodur H, Eren SS, Akinci E, Sener K, Onguru P, Kubar A. 2007. Viral load as a predictor of outcome in Crimean-Congo hemorrhagic fever. Clin Infect Dis 45:e96-100.
7. Duh D, Saksida A, Petrovec M, Ahmeti S, Dedushaj I, Panning M, Drosten C, Avsic-Zupanc T. 2007. Viral load as predictor of Crimean-Congo hemorrhagic fever outcome. Emerg Infect Dis 13:1769-1772.
8. Ergonul O. 2006. Crimean-Congo haemorrhagic fever. Lancet Infect Dis 6:203-214.
9. Ergonul O, Tuncbilek S, Baykam N, Celikbas A, Dokuzoguz B. 2006. Evaluation of serum levels of interleukin (IL)-6, IL-10, and tumor necrosis factor-alpha in patients with Crimean-Congo hemorrhagic fever. J Infect Dis 193:941-944.
10. Ergunay K, Kocak Tufan Z, Bulut C, Kinikli S, Demiroz AP, Ozkul A. 2014. Antibody responses and viral load in patients with Crimean-Congo hemorrhagic fever: A comprehensive analysis during the early stages of the infection. Diagn Microbiol Infect Dis 79:31-36.
11. Geisbert TW, Jahrling PB. 2004. Exotic emerging viral diseases: Progress and challenges. Nat Med 10:S110-S121.
12. Hutchinson KL, Rollin PE. 2007. Cytokine and chemokine expression in humans infected with Sudan Ebola virus. J Infect Dis S357-S363.
13. John CC, Opika-Opoka R, Byarugaba J, Idro R, Boivin MJ. 2006. Low levels of RANTES are associated with mortality in children with cerebral malaria. J Infect Dis 194:837-845.
14. Kaya A, Engin A, Guven AS, Icagasioglu FD, Cevit O, Elaldi N, Gulturk A. 2014a. Crimean-Congo hemorrhagic fever disease due to tick bite with very long incubation periods. Int J Infect Dis 15:e449-e452.
15. Kaya S, Elaldi N, Kubar A, Gursoy N, Yilmaz M, Karakus G, Gunes T, Polat Z, Gozel MG, Engin A, Dokmetas I, Bakir M, Yilmaz N, Sencan M. 2014b. Sequential determination of serum viral titers, virus-specific IgG antibodies, and TNF-alpha, IL-6, IL-10, and IFN-gamma levels in patients with Crimean-Congo hemorrhagic fever. BMC Infect Dis 14:416.
16. Lee YR, Liu MT, Lei HY, Liu CC, Wu JM, Tung YC, Lin YS, Yeh TM, Chen SH, Liu HS. 2006. MCP-1, a highly expressed chemokine in dengue haemorrhagic fever/dengue shock syndrome patients, may cause permeability change, possibly through reduced tight junctions of vascular endothelium cells. J Gen Virol 87:3623-3630.
17. Mahanty S, Bray M. 2004. Pathogenesis of filoviral haemorrhagic fevers. Lancet Infect Dis 4:487-498.
18. McElroy AK, Erickson BR, Flietstra TD, Rollin PE, Nichol ST, Towner JS, Spiropoulou CF. 2014. Ebola hemorrhagic Fever: novel biomarker correlates of clinical outcome. J Infect Dis 210:558-566.
19. O'Garra A, Murphy KM. 2009. From IL-10 to IL-12: How pathogens and their products stimulate APCs to induce T(H) 1 development. Nat Immunol 10:929-932.
20. Ozturk B, Tutuncu E, Kuscu F, Gurbuz Y, Sencan I, Tuzun H. 2010. Evaluation of factors predictive of the prognosis in Crimean-Congo hemorrhagic fever: New suggestions. Int J Infect Dis 16:e89-e93.
21. Papa A. 2010. Crimean-Congo hemorrhagic fever and hantavirus infections. In: Maltezou H, Gikas A, editors. Tropical and emerging infectious diseases. Kerala, India: Research Signpost, pp 49-73.
22. Papa A, Bino S, Velo E, Harxhi A, Kota M, Antoniadis A. 2006. Cytokine levels in Crimean-Congo hemorrhagic fever. J Clin Virol 36:272-276.
23. Papa A, Dalla V, Papadimitriou E, Kartalis GN, Antoniadis A. 2009. Emergence of Crimean-Congo haemorrhagic fever in Greece. Clin Microbiol Infect 16:843-847.
24. Papa A, Drosten C, Bino S, Papadimitriou E, Panning M, Velo E, Kota M, Harxhi A, Antoniadis A. 2007. Viral load and Crimean-Congo hemorrhagic fever. Emerg Infect Dis 13:805-806.
25. Papa A, Mirazimi A, Koksal I, Estrada-Pena A, Feldmann H. 2015a. Recent advances in research on Crimean-Congo hemorrhagic fever. J Clin Virol. 64:137-143.
26. Papa A, Yagci Caglayik D, Christova I, Tsergouli K, Korukluoglu G, Uyar Y. 2015b. Crimean-Congo hemorrhagic fever: CXCL10 correlates with the viral load. J Med Virol 87:899-903.
27. Reddy V, Mani RS, Desai A, Ravi V. 2014. Correlation of plasma viral loads and presence of Chikungunya IgM antibodies with cytokine/chemokine levels during acute Chikungunya virus infection. J Med Virol 86:1393-1401.
28. Rollins BJ, Yoshimura T, Leonard EJ, Pober JS. 1990. Cytokine-activated human endothelial cells synthesize and secrete a monocyte chemoattractant, MCP-1/JE. Am J Pathol 136:1229-1233.
29. Saksida A, Duh D, Wraber B, Dedushaj I, Ahmeti S, Avsic-Zupanc T. 2010. Interacting roles of immune mechanisms and viral load in the pathogenesis of crimean-congo hemorrhagic fever. Clin Vaccine Immunol 17:1086-1093.
30. Schnittler HJ, Feldmann H. 2003. Viral hemorrhagic fever-a vascular disease? Thromb Haemost 89:967-972.
31. Schwarz TF, Nsanze H, Longson M, Nitschko H, Gilch S, Shurie H, Ameen A, Zahir AR, Acharya UG, Jager G. 1996. Polymerase chain reaction for diagnosis and identification of distinct variants of Crimean-Congo hemorrhagic fever virus in the United Arab Emirates. Am J Trop Med Hyg 55:190-196.
32. Sun Y, Jin C, Zhan F, Wang X, Liang M, Zhang Q, Ding S, Guan X, Huo X, Li C, Qu J, Wang Q, Zhang S, Zhang Y, Wang S, Xu A, Bi Z, Li D. 2012. Host cytokine storm is associated with disease severity of severe fever with thrombocytopenia syndrome. J Infect Dis 206:1085-1094.
33. Watson DC, Sargianou M, Panos G. 2012. Interleukin-12 (IL-12)/IL-10 ratio as a marker of disease severity in Crimean-Congo hemorrhagic fever. Clin Vaccine Immunol 19:823-824.
34. Wauquier N, Becquart P, Padilla C, Baize S, Leroy EM. 2010. Human fatal Zaire ebola virus infection is associated with an aberrant innate immunity and with massive lymphocyte apoptosis. PLoS Negl Trop Dis 4:e837.
35. Whitehouse CA. 2004. Crimean-Congo hemorrhagic fever. Antiviral Res 64:145-160.
36. Yamada M, Kim S, Egashira K, Takeya M, Ikeda T, Mimura O, Iwao H. 2003. Molecular mechanism and role of endothelial monocyte chemoattractant protein-1 induction by vascular endothelial growth factor. Arterioscler Thromb Vasc Biol 23:1996-2001.